Richard Thomas Williams - Net Worth and Insider Trading
Richard Thomas Williams Net Worth
The estimated net worth of Richard Thomas Williams is at least $112,182 dollars as of 2024-11-13. Richard Thomas Williams is the Chief Medical Officer of Kinnate Biopharma Inc and owns about 42,333 shares of Kinnate Biopharma Inc (KNTE) stock worth over $112,182. Details can be seen in Richard Thomas Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Thomas Williams has not made any transactions after 2022-03-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Thomas Williams
Richard Thomas Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Thomas Williams owns 1 companies in total, including Kinnate Biopharma Inc (KNTE) .
Click here to see the complete history of Richard Thomas Williams’s form 4 insider trades.
Insider Ownership Summary of Richard Thomas Williams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNTE | Kinnate Biopharma Inc | 2022-03-14 | Chief Medical Officer |
Richard Thomas Williams Latest Holdings Summary
Richard Thomas Williams currently owns a total of 1 stock. Richard Thomas Williams owns 42,333 shares of Kinnate Biopharma Inc (KNTE) as of March 14, 2022, with a value of $112,182.
Latest Holdings of Richard Thomas Williams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc | 2022-03-14 | 42,333 | 2.65 | 112,182 |
Holding Weightings of Richard Thomas Williams
Richard Thomas Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Thomas Williams has made a total of 1 transactions in Kinnate Biopharma Inc (KNTE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kinnate Biopharma Inc is the acquisition of 40,000 shares on March 14, 2022, which cost Richard Thomas Williams around $338,800.
Insider Trading History of Richard Thomas Williams
- 1
Richard Thomas Williams Trading Performance
GuruFocus tracks the stock performance after each of Richard Thomas Williams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Thomas Williams is 5.56%. GuruFocus also compares Richard Thomas Williams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Thomas Williams within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Thomas Williams's insider trading performs compared to the benchmark.
Performance of Richard Thomas Williams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.3 | | | | | |
| Relative Return to S&P 500(%) | 8.04 | | | | | |
Richard Thomas Williams Ownership Network
Ownership Network List of Richard Thomas Williams
Ownership Network Relation of Richard Thomas Williams
Richard Thomas Williams Owned Company Details
What does Kinnate Biopharma Inc do?
Who are the key executives at Kinnate Biopharma Inc?
Richard Thomas Williams is the Chief Medical Officer of Kinnate Biopharma Inc. Other key executives at Kinnate Biopharma Inc include director & 10 percent owner James B. Tananbaum , 10 percent owner Foresite Capital Fund Iv, L.p. , and director & 10 percent owner Orbimed Capital Gp Viii Llc .
Kinnate Biopharma Inc (KNTE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kinnate Biopharma Inc Insider Transactions
Richard Thomas Williams Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Thomas Williams. You might contact Richard Thomas Williams via mailing address: C/o Kinnate Biopharma Inc., 11975 El Camino Real, Suite 101, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
